Meet Our Researchers

Fumiko Chino, MD

Dr. Chino and her team are prospectively quantifying and investigating the effects of financial toxicity—a term for the hardship that patients face from their medical expenses—for head and neck cancer patients. The ROI is supporting Dr. Chino’s work as part of the 2018 Innovative Projects in Radiation Oncology awards, which focused on funding research to address some of the field’s most pressing challenges.

Rachel Conklin, MMS, PA-C

Ms. Conklin and her team are exploring using telehealth to increase access to their radiation oncology survivorship program for patients who receive care at a community facility, which is in a rural area approximately 50 miles from their main campus. The ROI is supporting Ms. Conklin’s work as part of the 2018 Innovative Projects in Radiation Oncology awards, which sought to address some of radiation oncology’s highest priority topics, including access to care.

Peter Greer, PhD

Dr. Greer and his team are developing the WatchDog system that determines treatment delivery accuracy for radiation therapy patients in real-time and can prevent mistreatment. Dr. Greer received ROI’s inaugural research award to conduct the team’s first clinical demonstration of the WatchDog system as part of the ROI’s safety and quality initiative.

Karen Hoffman, MD, MHSc, MPH

Dr. Hoffman and her team are prospectively surveying prostate cancer patients to study how receiving counseling from a radiation oncologist in a multidisciplinary clinic increases their awareness of radiation therapy as a treatment option with a favorable side effect profile and whether it changes their treatment choice. The ROI selected Dr. Hoffman’s research for a 2018 Innovative Projects in Radiation Oncology award because of its emphasis on raising the profile of radiation therapy among patients.

Amar Kishan, MD

Dr. Kishan received the 2018 Publication Award in recognition of the outstanding research published in the manuscript, “Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy With Brachytherapy Boost and Disease Progression and Mortality in Patients With Gleason Score 9-10 Prostate Cancer.” As first author of the article, Dr. Kishan received a grant to build upon the research in the manuscript, which he is using to expand the multi-institutional consortium that he established and extend the investigation to the general category of high-risk prostate cancer.

Geoffrey Martin, MD

Dr. Martin and his team conducted a clinical trial using smartphone-connected technology to monitor lung cancer patients undergoing radiation therapy. ROI awarded Dr. Martin an Innovative Projects in Radiation Oncology grant to investigate the correlation between patient reported outcomes, the continuous biometric monitoring via smartphones and the side effects of radiation therapy.

Todd McNutt, PhD

Dr. McNutt and his team are using big data and machine learning approaches to develop better predictive models for toxicities associated with head and neck cancer and to create a clinical decision support tool to help provide patients with more personalized care. The ROI is supporting Dr. McNutt’s groundbreaking work to stimulate this emerging field of research using big data to improve the safety and quality of radiation therapy.

Nima Nabavizadeh, MD

Dr. Nabavizadeh and his team are prospectively studying whether stereotactic body radiation therapy (SBRT) can be safely used to help patients with hepatocellular carcinoma (HCC) and advanced cirrhosis as they await a liver transplant. The ROI is supporting Dr. Nabavizadeh’s work as part of the 2018 Innovative Projects in Radiation Oncology awards, which sought to address some of radiation oncology’s highest priority topics, including SBRT.

Nitin Ohri, MD

Dr. Ohri and his team are conducting a randomized clinical trial to determine if giving patients daily customized step count goals as measured and guided through fitness trackers could improve patients’ ability to tolerate concurrent chemoradiotherapy. With an Innovative Projects in Radiation Oncology grant from ROI, Dr. Ohri is exploring whether this relatively simple intervention can reduce the number of missed treatments, decrease treatment-related toxicities and improve quality of life for cancer patients.

Malolan S. Rajagopalan, MD, MBA

Dr. Rajagopalan developed the RadOnc Toolbox app that features evidence-based interventions for managing and preventing eight of the most common radiation-related toxicities and a number of other clinical tools. The ROI supported the development of the RadOnc Toolbox to provide practitioners with an evidence-based resource for toxicity management in order to improve outcomes for cancer patients and survivors.

Anand Shah, MD, MPH

Dr. Shah and his team developed novel episode-based Medicare payment definitions for stereotactic body radiation therapy (SBRT) to treat patients with early stage non-small cell lung cancer (NSCLC). As part of ROI’s value of radiation therapy initiative, Dr. Shah’s study included an exploration of whether an academic versus nonacademic setting has an impact on the relative value of SBRT compared with surgery.

David Sher, MD, MPH

Dr. Sher and his team conducted parallel comparative effectiveness and cost comparison studies for early-stage and locally advanced oropharyngeal cancer using two large databases, SEER-Medicare and the HealthCore Integrated Research Database (HIRD). The results from Dr. Sher’s ROI-funded study are providing important evidence about the value of radiation therapy in the treatment of oropharyngeal cancer.

Christopher Slatore, MD, MS

Dr. Slatore and his team conducted a comparative, mixed-method study to better understand the patient-centered outcomes associated with radiation therapy versus surgery for early stage non-small cell lung cancer (NSCLC.) Dr. Slatore's ROI-funded work on the value of radiation therapy for the treatment of lung cancer laid the groundwork for additional research now being supported by the National Cancer Institute.

Chad Tang, MD

Dr. Tang and his team are conducting an analysis to understand the barriers to access and costs associated with four treatment options for patients with prostate cancer—surgery, external beam radiation therapy, brachytherapy and active surveillance. The ROI is supporting Dr. Tang’s work as part of the 2018 Innovative Projects in Radiation Oncology awards, which focused on funding research to address some of the field’s most pressing challenges.

K. Ranh Voong, MD, MPH

Dr. Voong received the Outstanding Article Award in the 2017 ROI Value of RT Publication Awards in partnership with Advances in Radiation Oncology. She was honored for her work as the lead author on the manuscript titled, “Long-term Economic Value of Hypofractionated Prostate Radiation: Secondary Analysis of a Randomized Trial,” and received a grant to continue her research on the value of radiation therapy.